BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Indite Global - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://inditeglobal.com
X-WR-CALDESC:Events for Indite Global
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250911
DTEND;VALUE=DATE:20250913
DTSTAMP:20260708T115259Z
CREATED:20260708T113650Z
LAST-MODIFIED:20260708T115259Z
UID:2686-1757548800-1757721599@inditeglobal.com
SUMMARY:Workshop on Improving Biosimilar Regulations and Facilitating Access\, Geneva
DESCRIPTION:Biologic medicines have transformed the treatment of cancer\, autoimmune disorders\, diabetes\, and other life-threatening diseases. However\, their high cost continues to limit patient access\, particularly in low- and middle-income countries. Biosimilars with highly similar versions of reference biologics offer a strategic solution to this challenge by enabling more affordable therapies without compromising quality\, safety\, or efficacy. Yet\, the pathway for biosimilar development and approval remains complex\, requiring advanced manufacturing capacity\, rigorous analytical tools\, and harmonised regulatory standards. \nRecognising the challenges and opportunities\, the Third World Network (TWN) convened a “Workshop on Improving Biosimilar Regulation & Facilitating Access” at Appart’City Collection\, Genève Aéroport Ferney Voltaire\, Geneva\, on 11–12 September 2025 in Geneva\, Switzerland. \nObjectives \n\nExplore the growing opportunities within the biosimilar industry and unpack access challenges in developing countries\nUnderstand the evolving regulatory landscape for biosimilars and implications for the biosimilar industry and patient access.\nEvaluate critical  analytical considerations\, the importance of PK/PD studies\, and moving beyond clinical efficacy studies in the biosimilar regulatory process\nFacilitate collaborations among regulators from key developing countries\, global experts\, civil society representatives\, industry leaders\, and access advocacy groups to share insights on the latest advancements in biosimilar regulations.\n\nThe two-day workshop addressed critical issues surrounding the regulation of biosimilars. The workshop brought together an international panel of regulators\, technical experts\, policymakers\, academics\, and civil society representatives. It had participation from regulators in the African Medicine Agency\, Bangladesh\, Brazil\, Argentina\, Colombia\, Chile\, Egypt\, Ghana\, Malaysia\, India\, Indonesia\, Kenya\, Philippines\, South Africa\, Thailand and Vietnam. In addition to regulators\, the workshop had representation from Utrecht University (The Netherlands)\, Leiden University Medical Centre (The Netherlands)\, Biocon Biologics\, Sandoz\, Samsung Bioepis\, and the Finnish Medicines Agency (Fimea).
URL:https://inditeglobal.com/event/workshop-on-improving-biosimilar-regulations-and-facilitating-access-geneva/
CATEGORIES:Workshop on Improving Biosimilar
ATTACH;FMTTYPE=image/png:https://inditeglobal.com/wp-content/uploads/2026/07/Workshop-on-Improving.png
END:VEVENT
END:VCALENDAR